Original article

Screening and pathway analysis of autophagy-related genes in Alzheimer disease

  • SHENG Zhaoqing ,
  • LIU Xiaohong
Expand
  • Department of Neurology, Putuo People’s Hospital, Tongji University, Shanghai 200060, China

Received date: 2024-01-22

  Online published: 2024-11-11

Abstract

Objective Screen autophagy related genes of Alzheimer disease(AD) based on microarray analysis, conduct pathway analysis and identify key genes in order to explore potential pathogenesis and therapeutic targets. Methods The GSE33000 dataset was downloaded from GEO Database, and the differentially expressed genes of AD were obtained by R software limma package. Autophagy-related genes were downloaded from Human Autophagy Database, Human Autophagy Modulator Database and GeneCard Database, respectively, and the autophagy-related gene set was obtained. The AD autophagy-related genes were obtained through intersecting the differentially expressed genes with the autophagy-related gene set. The R software packages such as org.Hs.eg.db and clusterProfiler were used to perform gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, the online software Search Tool for the Retrieval of Interacting Genes (STRING) was used to conduct protein-protein interaction network analysis, and the key genes were predicted based on MCC algorithm. Results A total of 66 autophagy related genes were obtained, of which 41 genes were up-regulated and 25 genes were down-regulated. Gene enrichment analysis showed that cellular components in GO analysis were mainly enriched in phagocytic vesicle membrane, secretory granule membrane, membrane microdomain, late endosome, etc., and molecular functions were mainly enriched in Toll-like receptor binding, ubiquitin-like protein ligase binding, etc., and biological processes were enriched in regulation of autophagy, positive regulation of cellular catabolic process, response to lipopolysaccharide, regulation of inflammatory response, cellular response to external stimulus, etc. In KEGG enrichment analysis, the differentially expressed autophagy-related genes were mainly concentrated in NOD-like receptor signaling pathway, lipid and atherosclerosis, forkhead box protein O(FoxO) signaling pathway, etc. Our research completed the construction of protein-protein interaction (PPI), identified 10 key genes, and screened out that interleukin-6(IL-6) and signal transducer and activator of transcription 3(STAT3) were closely related to AD. Conclusions Ten key autophagy-related genes were obtained in this study, among which IL-6 and STAT3 are more closely related to AD.

Cite this article

SHENG Zhaoqing , LIU Xiaohong . Screening and pathway analysis of autophagy-related genes in Alzheimer disease[J]. Journal of Internal Medicine Concepts & Practice, 2024 , 19(04) : 236 -242 . DOI: 10.16138/j.1673-6087.2024.04.04

References

[1] Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease[J]. Lancet, 2021, 397(10284):1577-1590.
[2] 王刚, 齐金蕾, 刘馨雅, 等. 中国阿尔茨海默病报告2024[J]. 诊断学理论与实践, 2024, 23(3):219-256.
[3] Levine B, Kroemer G. Autophagy in the pathogenesis of disease[J]. Cell, 2008, 132(1):27-42.
[4] Pickford F, Masliah E, Britschgi M, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice[J]. J Clin Invest, 2008, 118(6):2190-2199.
[5] Nixon RA, Wegiel J, Kumar A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study[J]. J Neuropathol Exp Neurol, 2005, 64(2):113-122.
[6] Yu WH, Cuervo AM, Kumar A, et al. Macroautophagy-a novel β-amyloid peptide-generating pathway activated in Alzheimer’s disease[J]. J Cell Biol, 2005, 171(1):87-98.
[7] Menzies FM, Fleming A, Caricasole A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities[J]. Neuron, 2017, 93(5):1015-1034.
[8] Nilsson P, Loganathan K, Sekiguchi M, et al. Aβ secretion and plaque formation depend on autophagy[J]. Cell Rep, 2013, 5(1):61-69.
[9] Uddin MS, Mamun AA, Labu ZK, et al. Autophagic dysfunction in Alzheimer’s disease: cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis[J]. J Cell Physiol, 2019, 234(6):8094-8112.
[10] Motta V, Soares F, Sun T, et al. NOD-like receptors: versatile cytosolic sentinels[J]. Physiol Rev, 2015, 95(1):149-178.
[11] Jounai N, Kobiyama K, Shiina M, et al. NLRP4 negatively regulates autophagic processes through an association with beclin1[J]. J Immunol, 2011, 186(3):1646-1655.
[12] Zhang Y, Sauler M, Shinn AS, et al. Endothelial PINK1 mediates the protective effects of NLRP3 deficiency during lethal oxidant injury[J]. J Immunol, 2014, 192(11):5296-5304.
[13] Wlodarska M, Thaiss CA, Nowarski R, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion[J]. Cell, 2014, 156(5):1045-1059.
[14] Chen Y, Zeng A, He S, et al. Autophagy-related genes in atherosclerosis[J]. J Healthc Eng, 2021,2021:6402206.
[15] Shao BZ, Han BZ, Zeng YX, et al. The roles of macrophage autophagy in atherosclerosis[J]. Acta Pharmacol Sin, 2016, 37(2):150-156.
[16] Menghini R, Casagrande V, Marino A, et al. MiR-216a: a link between endothelial dysfunction and autophagy[J]. Cell Death Dis, 2014, 5(1):e1029.
[17] Li H, Huang S, Wang S, et al. Targeting annexin A7 by a small molecule suppressed the activity of phosphatidylcholine-specific phospholipase C in vascular endothelial cells and inhibited atherosclerosis in apolipoprotein E?/?mice[J]. Cell Death Dis, 2013, 4(9):e806.
[18] Roher AE, Esh C, Kokjohn TA, et al. Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer’s disease[J]. Arterioscler Thromb Vasc Biol, 2003, 23(11):2055-2062.
[19] Roher AE, Tyas SL, Maarouf CL, et al. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia[J]. Alzheimers Dement, 2011, 7(4):436-444.
[20] Arvanitakis Z, Capuano AW, Leurgans SE, et al. Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: a cross-sectional study[J]. Lancet Neurol, 2016, 15(9):934-943.
[21] Liu L, Tao Z, Zheng LD, et al. FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial uncoupling proteins via autophagy in adipocytes[J]. Cell Death Discov, 2016,2:16066.
[22] Wang S, Xia P, Huang G, et al. FoxO1-mediated autophagy is required for NK cell development and innate immunity[J]. Nat Commun, 2016,7:11023.
[23] Baek SH, Kim KI. Epigenetic control of autophagy: nuclear events gain more attention[J]. Mol Cell, 2017, 65(5):781-785.
[24] Hu F, Song D, Yan Y, et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation[J]. Nat Commun, 2021, 12(1):3651.
[25] Lyra E Silva NM, Gon?alves RA, Pascoal TA, et al. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease[J]. Transl Psychiatry, 2021, 11(1):251.
[26] 田密, 侯德仁, 邓炎尧, 等. STAT3与P-STAT3在转基因AD小鼠脑组织中的表达及意义[J]. 南方医科大学学报, 2013, 33(12):1778-1782.
[27] You L, Wang Z, Li H, et al. The role of STAT3 in autophagy[J]. Autophagy, 2015, 11(5):729-739.
[28] Reichenbach N, Delekate A, Plescher M, et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer’s disease model[J]. EMBO Mol Med, 2019, 11(2):e9665.
[29] Choi M, Kim H, Yang EJ, et al. Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer’s disease[J]. J Pharmacol Sci, 2020, 143(4):290-299.
[30] Sarkar S. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers[J]. Biochem Soc Trans, 2013, 41(5):1103-1130.
[31] Schmukler E, Michaelson DM, Pinkas-Kramarski R. The interplay between apolipoprotein E4 and the autophagic-endocytic-lysosomal axis[J]. Mol Neurobiol, 2018, 55(8):6863-6880.
Outlines

/